Synthesis, antitubercular activity and pharmacokinetic studies of some schiff bases derived from 1- alkylisatin and isonicotinic acid hydrazide (inh)

Brown, R. K., Snider, R. E., and Stevenson, M. D., Some indole derivatives tested for antitubercular activity.J. Org. Chem., 21, 261–262 (1956).

Buu-Hoi, N. P., Xuong, N. D., Nam, N. H., Binon, R, and Royer, R., Tuberculostatic hydrazides and their derivatives.J. Chem. Soc., 1358–1364 (1953).

Canetti, G., Rist, N., and Grosset, J., Measure de la sensibilite du bacille tuberculeux aux drogues antibacillaires par la methode des proportions.Rev. Tuber., 58, 111–114 (1983).

Conradi, R. A., Burton, P. S., and Borchardt, R. T., In Pliska, V., Testa, B. and Waterbeemd, H. (Eds.). Lipophilicity in Drug Action and Toxicology, A Series Monographs of Methods and Principles in Medicinal Chemistry. VCH. Wienheim; New york; Basel; Cambridge; Tokyo, Vol. 4, p. 233 (1996).

Daisley, R. W. and Shah, V. K., Synthesis and antibacterial activity of some 5-nitro-3-phenyliminoindole-2(3H)-one and theirN-Mannich bases.J. Pharm. Sci., 73, 407–408 (1984).

Dye, C, Williams, B. G., Espinal, M. A., and Raviglions, M. C, Erasing the Worlds Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis.Science, 295, 2042–2046 (2002).

Dye, C. and Williams, B. G., Criteria for the control of drugresistant tuberculosis.Proc. Nati. Acad. Sci. USA, 97, 8180–8185 (2000).

Ehud, K., Margalith, E., and Winer, B., Structure activity relations of thiosemicarbazones on vaccinia virus and IBT-dependent mutant.J. Antimicrob. Chemotherap., 2, 255–260 (1976).

El-Sebai, A. I., Soliman, R., and Rida, S. M., Synthesis of some new acid hydrazides structurally related to certain tuberculostatic agents.Egypt. J. Pharm. Sci., 14, 67–73 (1973).

Knotz, R, Production of antiviral and antimicrobial substances. 1. 1-Alkylisatin-3-acylhydrazones.Scientia Pharmaceutics, 38, 98–106 (1970).

Leo, A. J., Calculating log Poct from structures.Chem. Rev., 93, 1281–1306 (1993).

Mahfouz, N. M., Omar, F. A., and Aboul-Fadl, T., Cyclic amide derivatives as potential prodrugs:N-hydroxymethyl-succinimide-/isatin esters of some NSAIDs as chemical delivery system with improved therapeutic index.Eur. J. Med. Chem., 34, 551–562 (1999).

Majumdar, K. C, Kundu, A. K., and Chatterjee, P., 1-Alkylisatins via aldol-retro-aldol condensation.J. Chem. Research (S), 460–461 (1996).

Mondell, G. L. and Sande, M. A., In Gilman, A. G., Rull, T. W., Nies, A. S. and Taylor, P., The Pharmaceutical Basis of Therapeutics, 8th Ed., Pregamon press, New York, p. 1147 (1991).

Moss, J. and Bundgaard, H., Prodrugs of peptides. 7. Transdermal delivery of thyrotropin-releasing hormone (TRH) via prodrugs.Inter. J. Pharm., 66, 39–45 (1990).

NIAZI S., In Textbook of Biopharmaceutics and Clinical Pharmacokinetics, Appleton-Century-Crofts, New York, p. 151 (1992).

Pablos-Mendez, A., Gowda, D. K., and Frieden, T. R., Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.Bull World Health Organ, 80, 489–495 (2002).

Petrini, B. and Hoffiner, S., Drug-resistant and multidrug-resistant tubercle bacilli.International Journal of Antimicrobial Agents, 13, 293–97 (1999).

Piscopo, B., Diumo, M. V., Godliardi, R., Cucciniello, M., and Veneruso, G., Studies on heterocyclic compounds Indole-2,3-dione derivatives variously substituted hydrazones with antimicrobial activity.Bol. Soc. Ital. Biol. Sper., 63, 827–830 (1987).

Radul, O. M., Zhungietu, G. I., Rekhter, M. A., and Bukhanyuk, S. M., Simple method for the synthesis of 1-substituted isatins.Khimiya Geterotsiklicheskikh Soedinenii, 3, 353–355 (1983)

Selvam, P., Chandramohan, M., De Clercq, E., Witvrouw, M., and Pannecouque, C, Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-amino]-N(4,6-dirnethyl-2-pyhmidinyl)-benzenesulfonamide and its derivatives.European Journal of Pharmaceutical Sciences, 14, 313–316 (2001).

Seydel, J. K. and Schaper, K.J., The problem of resistance in the treatment ofMycobacterium infections: new experimental results and combinations for the treatment of tuberculosis and leprosy.Pharmazie in unsererZeit, 24, 313 (1995).

Shargel, L. and Andrew, B. C. In Applied Biopharmaceutics and Pharmaceutics, 3rd. Ed., Prentice-Hall International Co., Appleton & Lange, London, p. 174 (1993).

Silva, J. F. M. D., Garden, S. J., and Pinto, A. C, The Chemistry of Isatins: a Review from 1975 to 1999,J. Braz. Chem. Soc, 12, 273–324 (2001).

Somogyi, L. Transformation of Isatin 3-acylhydrazones under acetylating conditions: synthesis and structure elucidation of 1,5-disubstituted 3-acetylspiro[oxindole-3,2-[1,3,4]oxadia-zolines].Bull. Chem. Soc. Jpn., 74, 873–881 (2001).

Tomioka, H., Prospects for development of new antituberculous drugs.Kekkaku, 77, 573–584 (2002).